We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · January 05, 2022

IFN-γ PBMC Positivity May Identify Patients With T2D at Risk for DKA

The Journal of Clinical Endocrinology and Metabolism


Additional Info

The Journal of Clinical Endocrinology and Metabolism
Clinical significance of insulin peptide-specific interferon-γ-related immune responses in ketosis-prone type 2 diabetes
J. Clin. Endocrinol. Metab. 2021 Dec 18;[EPub Ahead of Print], A Satomura, Y Oikawa, A Haisa, S Suzuki, S Nakanishi, T Katsuki, A Shimada

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading